Skip to main content
Clinical Trials/NCT01553760
NCT01553760UnknownNot Applicable

The Use of an Anterior Chamber Maintainer as a Sole Fluid Source in Micro Incision Cataract Surgery as Compared to a Standard Phacoemulsification Procedure

Meir Medical Center1 site in 1 country20 target enrollmentStarted: March 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
20
Locations
1
Primary Endpoint
Corneal temperature

Study Overview

Brief Summary

The purpose of this study is to compare the use of an Anterior Chamber Maintainer (ACM) as the sole fluid source in phacoemulsification micro incision cataract surgery (using 1.1mm corneal incision) as opposed to conventional coaxial phacoemulsification (using 2.4mm corneal incision).

Detailed Description

Three-port Micro Incision Cataract Surgery (Tri-MICS) is a technique suggested by Professor Assia. The idea (principle) behind the Tri-MICS technique is the use of a sleeveless phaco needle which is introduced via a tiny incision (1.1mm). An additional corneal incision is made for the introduction of a second surgical instrument, and a third for an ACM as an exclusive source for the infusion - this saves the need for an additional instrument. The ACM that will be used in this study (AVI New York) is a small metal tube with an external diameter of 1.1 mm, and an internal diameter of 0.9 mm and was developed specifically for this use. This type of ACM has been used in hundreds of surgeries and has been found to be both effective and safe.

This procedure has 4 clear advantages:

  1. The implementation of three corneal incisions, 1.1 mm wide with an angle of approximately 120 degrees between them - neutrality regarding astigmatism versus the Biaxial-MICS.
  2. This procedure does not require any special medical instruments, for example; new phaco instruments which are specifically adapted for the MICS approach at the cost of tens of thousands of dollars.
  3. This procedure allows a free use of the surgeon's second hand.
  4. A fixed intraocular infusion keeps the intraocular pressure (IOP) and anterior chamber volume constant and stable.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Bilateral Cataract
  • Ability to understand and sign on an inform consent form.
  • whiling to undergo bilateral cataract surgery.

Exclusion Criteria

  • Mature Cataract
  • Corneal Pathology
  • Endothelial cell density<1500 cells/mm
  • Extreme Hyperopia / shallow anterior chamber
  • Extreme Myopia
  • s/p Ophthalmic Trauma / Surgery
  • Allergy to Penicillin / IOD

Outcomes

Primary Outcomes

Corneal temperature

Time Frame: up to 12 months

Continuous corneal temperature will be measured during cataract surgery using an infra red thermal imaging system

Secondary Outcomes

  • Anterior chamber stability(up to 12 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Abulafia Adi

MD

Meir Medical Center

Study Sites (1)

Loading locations...

Similar Trials

The Use of an Anterior Chamber Maintainer... | Clinical Trial